Showing results (231-240 of 298) with videos related to

Sort By:
Pageof 30
Haematologica|April 19, 2012
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trialAndreas L Petzer, Dominic Fong, Thomas Lion, et al.
Leukemia|August 16, 2022
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trialHeiner Zimmermann, Christian Koenecke, Martin H Dreyling, et al.
Haematologica|February 11, 2010
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" studyAndreas L Petzer, Dominik Wolf, Dominic Fong, et al.
European Journal of Haematology|July 31, 2018
Recommendations for the diagnosis and treatment of patients with polycythaemia veraAntónia Hatalova, Jiri Schwarz, Mirjana Gotic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous LeukemiaSieghart Sopper, Satu Mustjoki, Deborah White, et al.
Journal of Cancer Research and Clinical Oncology|August 7, 2023
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancerViktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, et al.
EMBO Molecular Medicine|April 24, 2014
Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2Ivan Tancevski, Manfred Nairz, Kristina Duwensee, et al.
Blood Advances|May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell LeukemiaJan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.
Blood|March 5, 2021
JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionalityTata Nageswara Rao, Nils Hansen, Jan Stetka, et al.
Medicine|May 20, 2016
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative NeoplasmJan Görtzen, Lena M Hunka, Maria Vonnahme, et al.
Pageof 30